• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症的治疗选择

Therapeutic options in osteoporosis.

作者信息

Dominguez Ligia J, Scalisi Rosalinda, Barbagallo Mario

机构信息

Geriatric Unit, Department of Clinical Medicine and Emergent Pathologies, University of Palermo, Italy.

出版信息

Acta Biomed. 2010;81 Suppl 1:55-65.

PMID:20518192
Abstract

Osteoporosis is a major and global public health concern. This disorder is characterized by a compromised bone strength and increased susceptibility to fractures, with important health and socioeconomic consequences. Age remains a cardinal, independent determinant of fracture risk; hence, the prevalence of osteoporotic fractures is expected to rise as the proportion of older populations increases worldwide. The prevention of osteoporosis should begin early and continue all the way through life with measures that improve or maintain bone health including regular physical activity and a balanced diet, considering not only an adequate intake of calcium but also of other minerals, proteins, and food rich in antioxidants. Smoking and alcohol abuse should be avoided. In older persons, who are particularly at risk of fragility fractures, the prevention of falls and the maintenance of an adequate vitamin D status are essential. Assessment of fracture risk followed by proved effective nonpharmacological and pharmacological management is still low, even in patients who have sustained a fragility fracture. Nonpharmacologic strategies should always be implemented, but many patients also need pharmacologic intervention to achieve adequate fracture protection. It is clear today that although low bone mineral density (BMD) is an important determinant of bone fragility, it is not the only one, hence, drugs used in the treatment of osteoporosis must not only show to promote changes in BMD, but to reduce the incidence of fractures. Safety issues should be always considered in an individual basis. This article reviews the available nonpharmacologic and pharmacologic interventions -proved to be effective- that may be implemented to reduce the risk of osteoporotic fractures.

摘要

骨质疏松症是一个重大的全球性公共卫生问题。这种疾病的特征是骨强度受损以及骨折易感性增加,会产生重要的健康和社会经济后果。年龄仍然是骨折风险的主要独立决定因素;因此,随着全球老年人口比例的增加,骨质疏松性骨折的患病率预计将会上升。骨质疏松症的预防应尽早开始,并贯穿一生,采取改善或维持骨骼健康的措施,包括定期进行体育活动和均衡饮食,不仅要考虑充足的钙摄入,还要考虑其他矿物质、蛋白质以及富含抗氧化剂的食物的摄入。应避免吸烟和酗酒。在特别容易发生脆性骨折的老年人中,预防跌倒和维持充足的维生素D水平至关重要。即使在发生过脆性骨折的患者中,骨折风险评估以及随后经证实有效的非药物和药物治疗的实施率仍然很低。应始终实施非药物策略,但许多患者也需要药物干预以实现足够的骨折预防。如今很明显,尽管低骨密度(BMD)是骨脆性的一个重要决定因素,但并非唯一因素,因此,用于治疗骨质疏松症的药物不仅必须显示出能促进骨密度变化,而且要降低骨折发生率。安全问题应始终根据个体情况加以考虑。本文综述了已被证明有效的非药物和药物干预措施,这些措施可用于降低骨质疏松性骨折的风险。

相似文献

1
Therapeutic options in osteoporosis.骨质疏松症的治疗选择
Acta Biomed. 2010;81 Suppl 1:55-65.
2
Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.绝经后妇女骨质疏松症的管理:北美绝经学会 2010 年立场声明。
Menopause. 2010 Jan-Feb;17(1):25-54; quiz 55-6. doi: 10.1097/gme.0b013e3181c617e6.
3
Prevention, screening, and management of osteoporosis: an overview of the current strategies.骨质疏松症的预防、筛查与管理:当前策略概述
Postgrad Med. 2009 Jul;121(4):5-17. doi: 10.3810/pgm.2009.07.2021.
4
Prevention of osteoporotic fractures in the elderly.老年人骨质疏松性骨折的预防
Am J Med. 2005 Nov;118(11):1190-5. doi: 10.1016/j.amjmed.2005.06.046.
5
[Up-to-date treatments for osteoporosis].[骨质疏松症的最新治疗方法]
Orv Hetil. 2006 Feb 19;147(7):301-6.
6
Osteoporosis: strategies for prevention and management.骨质疏松症:预防与管理策略
Best Pract Res Clin Rheumatol. 2007 Feb;21(1):109-22. doi: 10.1016/j.berh.2006.10.004.
7
Preventing osteoporotic fractures in older people.预防老年人骨质疏松性骨折。
Practitioner. 2011 Jan;255(1736):19-22, 2-3.
8
Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.绝经后骨质疏松症的管理:北美更年期协会立场声明
Menopause. 2002 Mar-Apr;9(2):84-101.
9
Pathogenesis and management of primary osteoporosis.原发性骨质疏松症的发病机制与管理
Clin Pharm. 1986 Aug;5(8):639-59.
10
Fighting the fracture cascade: evaluation and management of osteoporotic fractures.对抗骨折连锁反应:骨质疏松性骨折的评估与管理
Postgrad Med. 2008 Nov;120(4):51-7. doi: 10.3810/pgm.2008.11.1938.

引用本文的文献

1
A meta-analysis of the therapeutic effect of intranasal salmon calcitonin on osteoporosis.鼻内鲑鱼降钙素治疗骨质疏松症的疗效的荟萃分析。
Eur J Med Res. 2021 Dec 8;26(1):140. doi: 10.1186/s40001-021-00610-x.
2
Multiple Porous Synthetic Bone Graft Comprising EngineeredMicro-Channel for Drug Carrier and Bone Regeneration.包含用于药物载体和骨再生的工程微通道的多孔合成骨移植物
Materials (Basel). 2021 Sep 15;14(18):5320. doi: 10.3390/ma14185320.
3
Soluble Biomarkers of Osteoporosis and Osteoarthritis, from Pathway Mapping to Clinical Trials: An Update.
骨质疏松症和骨关节炎的可溶性生物标志物:从途径映射到临床试验的更新。
Clin Interv Aging. 2020 Apr 8;15:501-518. doi: 10.2147/CIA.S242288. eCollection 2020.
4
Wicking Property of Graft Material Enhanced Bone Regeneration in the Ovariectomized Rat Model.移植材料的吸湿排汗特性增强去卵巢大鼠模型中的骨再生
Tissue Eng Regen Med. 2018 Jul 13;15(4):503-510. doi: 10.1007/s13770-018-0142-x. eCollection 2018 Aug.
5
[Human osteoprotegerin inhibits osteoclasts and promotes hydroxyapatite to repair the mandibular defects in ovariectomized rats].[人骨保护素抑制破骨细胞并促进羟基磷灰石修复去卵巢大鼠下颌骨缺损]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2018 Aug 1;36(4):367-371. doi: 10.7518/hxkq.2018.04.004.
6
Alcohol Inhibits Odontogenic Differentiation of Human Dental Pulp Cells by Activating mTOR Signaling.酒精通过激活mTOR信号通路抑制人牙髓细胞的牙源性分化。
Stem Cells Int. 2017;2017:8717454. doi: 10.1155/2017/8717454. Epub 2017 Sep 14.
7
Effect of OPG gene mutation on protein expression and biological activity in osteoporosis.骨保护素(OPG)基因突变对骨质疏松症中蛋白质表达及生物学活性的影响
Exp Ther Med. 2017 Aug;14(2):1475-1480. doi: 10.3892/etm.2017.4712. Epub 2017 Jun 28.
8
Effects of OsteoKing on osteoporotic rabbits.骨王对骨质疏松兔的影响。
Mol Med Rep. 2015 Jul;12(1):1066-74. doi: 10.3892/mmr.2015.3551. Epub 2015 Mar 26.
9
The functional mechanism of simvastatin in experimental osteoporosis.辛伐他汀在实验性骨质疏松症中的作用机制。
J Bone Miner Metab. 2016 Jan;34(1):23-32. doi: 10.1007/s00774-014-0638-y. Epub 2014 Dec 17.
10
The role of healthy diet in the prevention of osteoporosis in perimenopausal period.健康饮食在围绝经期骨质疏松症预防中的作用。
Pak J Med Sci. 2014 Jul;30(4):763-8. doi: 10.12669/pjms.304.4577.